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A determinação de nimesulida em formulações farmacêuticas na faixa de 10,38 a 39,47% m/m 
foi estudada e validada empregando figuras de mérito, espectroscopia no infravermelho próximo 
e calibração multivariada baseada no método dos mínimos quadrados parciais (PLS) e no sinal 
analítico líquido (NAS). Resultados satisfatórios foram obtidos com limite de detecção de 
0,61%, limite de quantificação de 2,03%, erro médio quadrático de predição (RMSEP) de 1,05%, 
seletividade média 0,006, sensibilidade de 0,004%, inverso da sensibilidade analítica de (0,20%)-1 
e relação sinal-ruído de 181. Além disso, obtiveram-se erros relativos menores que 10%, que são 
valores aceitáveis para o controle de qualidade desse fármaco. Esses resultados indicam que o 
método proposto pode ser utilizado na indústria farmacêutica como uma alternativa ao procedimento 
padrão de análise.
The determination of nimesulide in pharmaceutical formulation in the range of 10.38 to 
39.47% m/m using near infrared spectroscopy and multivariate calibration based on partial least 
squares (PLS) and net analyte signal (NAS) was studied and validated by establishing its figures 
of merit. Suitable results were obtained, with limit of detection of 0.61%, limit quantification of 
2.03%, accuracy estimated as root mean square error of prediction (RMSEP) of 1.05%, mean 
selectivity of 0.006, sensitivity of 0.004%, inverse analytical sensitivity of (0.20%)-1 and signal-
to-noise ratio of 181. In addition, it was obtained relative errors lower than 10% that are acceptable 
values for quality control of this drug. These results indicate that the proposed method can be used 
in pharmaceutical industries as an alternative to standard analytical procedures.
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Introduction
Nimesulide is a non-steroidal anti-inflammatory drug 
(NSAID) with analgesic and antipyretic properties and 
its approved indications are the treatment of acute pain, 
the symptomatic treatment of osteoarthrosis and primary 
dysmenorrhoea in adolescents and adults above 12 years 
old.1 It is among the top 5 non-steroidal anti-inflammatory 
drugs worldwide2 and its chemical structure is shown in 
Figure 1. Excipients3 usually found in pharmaceutical 
products which have the drug nimesulide are: powdered 
cellulose, monohydrate lactose, sodium lauryl sulphate, 
magnesium stearate, croscarmellose sodium, and povidone. 
Both powdered cellulose and lactose monohydrate are used 
as diluents while sodium lauryl sulphate and magnesium 
stearate are used as lubricant. Croscarmellose sodium is 
used as a disintegrant. In tableting, povidone is used in the 
binders wet granulation processes. 
For the determination of nimesulide content, European 
Pharmacopoeia recommends potentiometric titration 
in water-acetone (30:20 v/v) using 0.1 mol L-1 sodium 
hydroxide as titrant.4 Also, it has been quantified 
mainly in pharmaceutical formulations by HPLC with 
spectrophotometry and mass spectrometry.5 There is also 
report of application for the determination of nimesulide 
using electrochemical detection.6 While these techniques 
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are accurate, they are tedious and time-consuming and 
require extensive sample preparation.
In recent years, the advantages of near infrared 
spectroscopy (NIR) over other analytical techniques have 
increased its acceptance in various analytical science fields.7 
Most of the advantages of NIR spectroscopy come from 
the possibility of using intact samples presented directly to 
the instrument without any pre-treatment. This fact implies 
in promoting non-conventional interaction of the radiation 
with matter in order to extract the spectral information and 
generate many different measurement modes.
NIR spectroscopy has proved to be a suitable tool for 
pharmaceutical analysis,8 providing the basis for predicting 
several chemical9 and physical properties from a single 
spectrum sample.10 By means of powerful multivariate 
techniques such as partial least-squares regression (PLS), 
each property of interest can be regressed against the NIR 
spectra, resulting in a calibration model that can be used, 
in sequence, to predict the property values for a given test 
sample.
Recently, a new multivariate method has been proposed 
based on the concept of net analyte signal (NAS). Based on 
Lorber’s definition11 for spectroscopic methods, the NAS 
is the part of the sample spectrum that is orthogonal to the 
space spanned by the spectra of all constituents except the 
analyte, i.e., all interfering constituents (Figure 2). Since the 
NAS vector indicates a direction only affected by changes in 
the analyte concentration, it can be used in a fully selective 
procedure for the analyte determination.
For the calculation of the NAS, the matrix X, referent 
to the sample spectra, is rebuilt based on A latent variables 
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 is the concentration vector projected down onto 
the A-dimensional space calculated by PLS and the ‘+’ 
superscript is the Moore-Penrose pseudo inverse.






 can be written as:
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only the information of analyte k, thus it is possible to 
replace it by its Euclidean norm, generating a scalar nâs: 
  (3)
since the experimental responses of analyte k can be 
expressed as a scalar value, an univariate inverse calibration 
model can be built by the least squares method as:
  (4)
where nâs and y are the NAS and the reference values for 




 is the regression coefficient 
of the pseudo univariate model. A more detailed description 
of NAS calculation can be found elsewhere.13
The NAS also offers the possibility of estimating 
analytical figures of merit and method performance. 
Figures of merit are parameters used for characterization, 
comparison or development of new analytical methods. 
Different figures of merit such as limit of detection, limit 
of quantification, sensitivity and selectivity have been 
reported in the literature to quantify the quality of a given 
multivariate model.13,14
The knowledge of the detection or quantification limits 
for a given analytical method and for a specific analyte can 
help the development and the validation of accurate models 
for determining low analyte contents.
The aims of this work were to built and validate 
multivariate calibration models for determination of 
nimesulide in pharmaceutical formulation using near 
infrared spectroscopy. For this purpose, figures of merit 
such as: sensitivity, analytical sensitivity, selectivity, 
accuracy and signal to-noise ratio were calculated, and 
the model results were compared with reference values 
obtained by standard methods to confirm the applicability 
of the proposed method.
Figure 2. Geometrical representation of NAS vector. The NAS vector is 
orthogonal to the space spanned by the interferent vectors.
Figure 1. Chemical structure of nimesulide. 
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Analytical figures of merit
Accuracy
This figure reports the closeness of the agreement 
between the reference value and the value found by the 
calibration model. In multivariate calibration, this is 
generally expressed as the root mean square error of the 
prediction (RMSEP), that is an approximation of the 
standard error of the prediction samples, obtained as:15
 
   (5)
where n is the number of prediction samples.
Signal-to-noise ratio
This parameter represents how much the signal of the 
analyte is larger than the instrumental noise. In the present 
case, this is calculated for each sample as: 
  (6)
where dx is an estimate for the instrumental noise. The 
instrumental noise was calculated by recording ten spectra 
for ten blank samples, calculating the norm of the NAS 
for each sample, and the corresponding pooled standard 
deviation.13
Sensitivity
The sensitivity indicates to what extent the response 
due to a particular analyte varies as a function of its 
concentration. In inverse multivariate calibration models, 
it is defined as:14
  (7)




nas  must be the same for 




nas  is the vector for the net analyte 
signal for the k analyte and y
i
 is the reference value of the 
sample i. A unique value of sensitivity can be estimated as:
  (8)
Analytical Sensitivity 
The analytical sensitivity, γ, which is defined in analogy 
to univariate calibration, is calculated as:
 (9)
The minimum concentration difference which is 
statistically discernible by a method can be expressed as 
γ−1 (γ−1 = 1/γ). Thus, the inverse of the analytical sensitivity 
establishes a minimum concentration difference that 
is discernible by the analytical method considering the 
random experimental noise as the only source of error, 
regardless of the specific technique employed.
Selectivity
Selectivity is defined in multivariate calibration by the 
ratio of the scalar nas
i
 for each sample and the Euclidean 
norm of the original vector of the instrumental responses: 
  (10)
where the subscript “i” is the reference value of the sample i.
Limit of detection (LOD) 
Following the IUPAC recommendations, the LOD can 
be defined as the minimum detectable value of net signal 
(or concentration) for which the probabilities of false 
negatives (b) and false positives (a) are 0.05.16 The LOD 
can be calculated analogously as for univariate calibration:17
 (11)
Limit of quantification ( LOQ)
The ability of quantification is generally expressed 
in terms of the signal or analyte concentration value that 
will produce estimates having a specified relative standard 
deviation.16 Following the same assumptions described 
above, the LOQ in multivariate calibration has been 
calculated by:18
 (12)
It should be emphasized that according to official 
guidelines and the aims of the proposed method, 
estimations of LOD and LOQ are not required. However, 
they were calculated because this information can be 
relevant in others determinations.
Bias 
According to the IUPAC definition,16 bias is the 
difference between the population mean and the true value. 
Systematic errors are all error components that are not 
random. Then, it is possible to equate systematic errors 
with the fixed bias of the chemical measurement process. 
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The occurrence of systematic errors was investigated by a 
t-test described in the ASTM E1655-00.19 Firstly, an average 
bias is calculated for the validation set:
 (13)
where n is the number of samples in the validation set. Then 
the standard deviation of validation (SDV) is obtained by:
 
  (14)
Finally, the t value is given by:
  (15)
If the t calculated is greater than the critical t value at 
the 95% confidence level, there is evidence that the bias 
included in the multivariate model is significant. 
Experimental
It was prepared 69 synthetic samples containing the 
active principle (nimesulide) in the range 10.38-39.47% m/m 
in excipient (powdered cellulose, sodium lauryl sulphate, 
magnesium stearate, croscarmellose sodium, povidone, and 
monohydrate lactose), according to the ternary diagram 
shown in Figure 3. As lactose is the main excipient 
component, in the experimental design proposed for sample 
preparation, it was considered a single factor (such as 
the nimesulide). A mixture of other excipients was also 
considered a single factor.
Adopting the same experimental conditions, three lots 
of commercial samples of nimesulide pharmaceutical 
formulation were also analyzed. The concentrations of 
these samples were previously established using the 
standard method used in the pharmaceutical industry based 
on dilution followed by spectrophotometric measurement 
in the UV region. The results obtained by the standard 
method were compared with those obtained by proposed 
NIR methodology and the errors were estimated.
 All samples were weighted in an analytical balance with 
accuracy of 0.00001 g and samples with total mass of 200 mg 
were prepared. In this preparation, the solid constituents of 
the pharmaceutical formulation were mixed during 5 min 
using a vortex for homogenization and finally they were put 
into a mill for 1 min. It was used approximately 10 mg of 
the mixture for spectrometric measurements.
The spectra were collected at a Thermo Nicolet Antaris 
FT-NIR Analyser, equipped with a tungsten filament 
source, integration sphere module and a AsInGa detector. 
Acquisition of the spectra was accomplished in the range 
of 4000-10000 cm-1 using 32 scans and resolution of 
4 cm-1. Data analysis was performed in Matlab version 
6.5 using routines developed in our laboratory and using 
PLS Toolbox, version 4.21 from Eigenvector Technologies. 
Results and Discussion
The first step for the model development was split the 
samples in calibration set (49 samples) and validation 
set (20 samples) using the Kennard-Stone algorithm.20 
The diffuse reflectance NIR spectra of the samples are 
presented in Figure 4. It is possible to observe additive/
Figure 3. Experimental design for sample preparation. *Other excipients: 
powdered cellulose, sodium lauryl sulphate, magnesium stearate, 
croscarmellose sodium, and povidone. Figure 4. NIR spectra of nimesulide samples.
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Figure 5. NIR spectra of nimesulide samples after correction with MSC.
Figure 6. Plot of predicted versus reference values for nimesulide by PLS. 
Calibration (o) and validation (+) samples.
Figure 7. Plot of NAS versus reference values for nimesulide. Calibration 
(o) and validation (+) samples.
significant difference in the determination of concentrations 
of nimesulide in pharmaceutical formulation given by the 
two models. 
The value found for the paired t-test was 0.84 and the 
critical value of t is 2.09 (P = 0.05). Then, it was concluded 
that the methods do not provide significantly different 
values for determination of nimesulide in pharmaceutical 
formulation. 
Furthermore, the percentile relative errors concerning 
these fits are shown in Figures 8 and 9. In these figures, the 
calibration samples errors present a random distribution, 
indicating a suitable fit. The calculation of the relative errors 




 contains the values for concentration of nimesulide and 
y
pred is the value predicted by the model.
Also, in these figures, it is possible to notice, that the 
majority of predictable samples have relative errors lower 
than ±6% that are acceptable limits for quality control.22
Figure 8 refers to the PLS model errors. Analyzing 
this figure it is possible to notice that only 3 validation 
samples have errors higher than 4%. However, in Figure 9, 
which shows the errors related to the adjust of the pseudo-
univariate model, there are 8 validation samples with errors 
greater than 4%. 
On the other hand, analyzing all the validation samples 
it is possible to assume that most of them present errors 
of the same level, as a result these models do not have 
significant differences as shown in the paired t-test.
multiplicative effects in spectral data, typical of solid 
measurements. These effects were corrected by the 
utilization of MSC (multiplicative scatter correction), 
while for the concentration vector no pre-processing was 
used. The spectra after scattering correction are shown 
in Figure 5. 
The PLS model was built using 6 latent variables. 
This number was chosen because it presented a lower root 
mean squares error of cross-validation (RMSECV) and 
explains 100% of X variance and 99.93% of y. Therefore, 
a calibration model was also built in its pseudo univariate 
form using NAS. In the following Figures 6 and 7 the 
reference values are shown against the predicted values 
using PLS and pseudo-univariate model, respectively. It is 
possible to notice a good fit between the reference values 
and the ones predicted by the models. Besides that, for 
this adjust comparison, it was performed a paired t-test,21 
considering the null hypothesis in which there is no 
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The validation of the multivariate calibration model 
was performed by the determination of parameters known 
as figures of merits. Results for the figures of merit are 
presented in Table 1. Accuracy values represented by 
RMSECV (root mean square error of cross validation), 
RMSEC (root mean square error of calibration) and 
RMSEP (root mean square error of prediction) show that 
the estimated values are close to the reference ones prepared 
in laboratory, since those values are about 1%. Therefore, 
it is possible to conclude that these errors are acceptable 
for quality control of nimesulide in pharmaceutical 
formulation.22 Regarding the signal-to-noise ratio, it was 
found the maximum value of 181, which means that 
the scalar NAS is approximately 181 greater than the 
instrumental noise. This result shows that the obtained 
signal suffers small influence from the instrumental noise 
which allows reaching even smaller values of detection 
and qualification limits. Considering the detection and 
quantification limit values, it can be concluded that the 
developed NIR model can only detect values higher than 
0.61% of nimesulide and for quantification the model 
cannot determine values below 2.03% of nimesulide. 
Since the concentration of nimesulide varies in the range 
of 10.38-39.47%, the proposed method can be considered 
efficient to detect and quantify this active principle in 
pharmaceutical formulations. The model presented a 
low sensitivity value (0.004%)-1, probably due to the 
preprocessing applied in the spectral data. The value for 
the inverse analytical sensitivity, presented in Table 1, can 
be interpreted in a clearer way, since it has a direct relation 
with the concentration. According to this value, the model 
is able to distinguish samples with different concentrations 
in the order of 0.2%. Since the concentration values among 
the samples are higher than 0.2%, the model is suitable 
to differentiate all samples here used. The value found 
for the model selectivity was 0.006. It means that, about 
less than 1% of the information of the analyte contained 
in the spectrum of the sample is orthogonal to the space 
of interferences, or, used for the model development. The 
selectivity indicates that around 99% of the analytical signal 
is removed during the NAS calculation. This result suggests 
that, for the multivariate calibration model, the selectivity 
parameter only informs the quantity of the original signal 
used by the model. 
The quantitative measurement of linearity in multivariate 
calibration models is not simple, or even possible. 
Qualitatively the plot of the errors of the calibration and 
validation samples can indicate whether the data follows 
a linear behavior or not. The random distribution of these 
errors is an indication of linear behavior. Figures 8 and 9 
show a random distribution of the errors and consequently 
a linear behavior. Another way to visualize this behavior 
is the plot of the first latent variable of PLS model against 
the nimesulide concentration. Figure 10 presents this plot, 
where it is clearly observed a tendency to a linear behavior. 
It must be pointed out that in this analysis it was taken into 





Analytical sensitivitya 4. 9
Selectivity 0.006
S/N ratio Maximum 181
Limit of detectiona 0.61
Limit of quantificationa 2.03
aResults in % nimesulide. bResults in % nimesulide-1.
Figure 8. Relative errors obtained by the PLS model. Calibration () 
and validation (+) samples.
Figure 9. Relative errors obtained by the pseudo-univariate model. 
Calibration () and validation (+) samples.
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account only the first latent variable that explains most part 
of the data variance. Consequently the points that present 
a deviation of linear behavior should not be understood 
as linear deviations, because the PLS model uses 6 latent 
variables. 
The presence of relevant bias was tested with the 
predicted results for the validation samples by the t-test 
suggested by ASTM E1655-00.19 The results showed that 
the bias included in the model was not significant, since 
the t value obtained of 0.31 is lower than the critical value 
of 2.10 with 95% of confidence.
In respect to the commercial samples of three 
different lots, compared with the standard method based 
on extraction and UV-analysis, errors calculated using 
equation 16 were 3, 5 and 6%. The results obtained can be 
considered satisfactory, since errors lower than 6% were 
obtained and they are acceptable for quality control.
Conclusions 
The determination of the nimesulide in pharmaceutical 
formulations was accomplished using diffuse reflectance 
NIR spectroscopy and multivariate calibration based on 
PLS and NAS. The models were built and validated by 
determination of the figures of merit, obtaining feasible 
and acceptable results. The prediction errors estimated 
were all below to 7% and it was possible to determine the 
limits of detection and quantification. The method showed 
a large sensitivity capacity, differentiating concentrations 
of 0.2%. The values for linearity, selectivity, and S/N ratio 
also showed results in acceptable levels that make the 
application of the proposed method as a possible alternative 
to the standard method, which is based on that extraction 
and UV-analysis. 
Figure 10. Scores of the 1st latent variable versus the nimesulide % in 
the calibration samples.
It can also be concluded that by using NAS it was 
possible to developed models of multivariate calibration 
in a pseudo-univariate calibration, similar to univariate 
calibration, making clearer the results interpretation. 
Moreover, the proposed method allows the analysis of 
a given sample in less than 3 min, while the analysis 
used by the pharmaceutical industry takes approximately 
30 min. This demonstrates the rapidity of the proposed 
method compared to the standard method used by the 
pharmaceutical industry.
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